iCAD Highlights Expanded Suite of Leading Breast Health AI Solutions at Virtual RSNA 2020

Groundbreaking ProFound AI Risk Helps Transform Breast Cancer Screening from an Age-Based Paradigm to Risk-Adapted Precision Screening, Individualized for Each Woman

NASHUA, N.H., Nov. 30, 2020 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the Company is showcasing its leading Breast Health Solutions, including the expanded ProFound AI® platform powered by Panorama, at the 106th Scientific Assembly and virtual Annual Meeting of the Radiological Society of North America (RSNA), November 29 – December 5.

The Company’s full suite of solutions includes the latest generation of ProFound AI for Digital Breast Tomosynthesis (DBT), the first artificial intelligence (AI) cancer detection software for DBT to be cleared by the US Food & Drug Administration, as well as ProFound AI for 2D Mammography,* and ProFound AI Risk for 2D mammography, the first and only commercially available clinical decision support tool that provides an accurate two-year breast cancer risk estimation based solely on a screening mammogram.

“Our efforts to commercialize pioneering solutions positioned to enhance patient care and improve outcomes is underscored by the superior performance and unrivaled specificity of our breast imaging AI that is transforming breast cancer detection and risk-based, personalized screening,” said Michael Klein, Chairman and CEO of iCAD. “We’re thrilled to highlight our expanded ProFound AI platform powered by Panorama at RSNA 2020, which is poised to further boost radiologists’ performance, improve detection and care, and is uniquely positioned to address the ongoing challenges presented by COVID-19.”

“Our new ProFound AI Risk is helping to change the way breast cancer risk is assessed and contribute to the acceleration of breast cancer screening from an aged-based screening paradigm to a risk-adapted screening paradigm,” continued Klein. “It is extremely gratifying to fulfill our panoramic vision of providing a complete clinical approach with a broader view of each patient’s case, history, and short-term risk, for truly personalized and enhanced patient care.”

ProFound AI Risk was created from a relationship between iCAD and leading researchers at the Karolinska Institutet in Stockholm, Sweden. This partnership is built upon a previous research agreement whereby researchers at the Karolinska Institutet developed a breast cancer risk prediction model using information identified in mammography images provided by iCAD’s AI solutions. The clinical decision support tool combines aspects within mammographic images, as well as age and breast density, to provide a highly accurate short-term risk estimation that is specific to each woman.

“The Profound AI Risk model performs better than any other current model,” according to Per Hall, MD, Professor/Senior Physician at the Karolinska Institutet. “The model is a short-term risk model which is an advantage in the screening setting, builds heavily on analyses of mammograms, is easy and inexpensive to implement and has little requirement of staff and systems to manage the data. Further, the risk model was also tested using other variables, such as lifestyle factors and genetic determinants, which may be added to the iCAD product in the future.”

Compelling research published in the peer-reviewed journal, Radiology, reveals that ProFound AI Risk significantly outperforms existing breast cancer risk models.

Trained with one of the largest available DBT datasets, ProFound AI rapidly and accurately analyzes each DBT image, or slice, and provides radiologists with key information, such as Certainty of Finding lesion and Case Scores, which assists in clinical decision-making and improving reading efficiency. Featuring the latest in deep-learning artificial intelligence, the algorithm allows for continuously improved performance in detection via ongoing updates. ProFound AI for DBT and 2D mammography* is compatible with a majority of leading DBT and digital 2D mammography systems.

About iCAD, Inc.

Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions.

ProFound AI for DBT is proven to curtail workflow challenges substantially by reducing radiologists’ reading time by 52.7 percent, thereby reducing by half the amount of time it takes radiologists to read 3D mammography datasets. Additionally, the platform improved radiologists’ sensitivity by 8 percent and reduced unnecessary patient recall rates by 7 percent.i

ProFound AI Risk is currently available on an introductory basis for 2D mammography and will subsequently be available for the rapidly growing 3D mammography market.

For more information, visit www.icadmed.com and www.xoftinc.com

Forward-Looking Statements

Certain statements contained in this News Release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the future prospects for the Company’s technology platforms and products. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited, to the Company’s ability to achieve business and strategic objectives, the willingness of patients to undergo mammography screening in light of risks of potential exposure to Covid-19, whether mammography screening will be treated as an essential procedure, whether ProFound AI will improve reading efficiency, improve specificity and sensitivity, reduce false positives and otherwise prove to be more beneficial for patients and clinicians, the impact of supply and manufacturing constraints or difficulties on our ability to fulfill our orders, uncertainty of future sales levels, to defend itself in litigation matters, protection of patents and other proprietary rights, product market acceptance, possible technological obsolescence of products, increased competition, government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company’s filings with the Securities and Exchange Commission. The words “believe,” “demonstrate,” “intend,” “expect,” “estimate,” “will,” “continue,” “anticipate,” “likely,” “seek,” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at http://www.icadmed.com and on the SEC’s website at http://www.sec.gov.

*CE Mark countries only.

Media Inquiries:

Amy Cook, iCAD
+1 (925) 200-2125
[email protected]

Investor Relations:

Jeremy Feffer, LifeSci Advisors
+1 (212) 915-2568
[email protected]


i Conant, E et al. (2019). Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiology: Artificial Intelligence. 1 (4). Accessed via https://pubs.rsna.org/doi/10.1148/ryai.2019180096



Equillium to Host Virtual Investor and Analyst Day on December 4, 2020

Review
p
ositive
i
nterim
d
ata
from
the
study
of
i
tolizumab
for the treatment of
a
cute GVHD
and
p
ipeline
p
rograms in
lupus /
l
upus
n
ephritis and
uncontrolled
a
sthma

Featur
ed
g
uest
s
peaker:
John Koreth, M
.
D
.
, D
.
Phil
.
of Dana-Farber Cancer Institute

LA JOLLA, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that it will host a virtual Investor and Analyst Day on December 4, 2020, from 9:30 a.m. to 12:00 p.m. ET. The event will include a review of the company’s lead clinical drug candidate, itolizumab, a first-in-class monoclonal antibody, which is being investigated in ongoing trials in acute graft-versus-host disease (aGVHD), lupus / lupus nephritis and uncontrolled asthma.

Presenters include:

John Koreth, M.D., D.Phil. of Dana-Farber Cancer Institute
  Providing a physician’s perspective on itolizumab in GVHD
Bruce Steel, Chief Executive Officer
Steve Connelly, Ph.D., Chief Scientific Officer
Krishna Polu, M.D., Chief Medical Officer
Joel Rothman, SVP Development Operations
Jason Keyes, Chief Financial Officer

The presentations will be followed by Q&A with management and Dr. Koreth.

A live webcast of the event will be available for 30 days on the Events & Presentations page of the Investor Relations section of the Company’s website at https://ir.equilliumbio.com/events-and-presentations.

About Itolizumab

Itolizumab is a clinical-stage, first-in-class monoclonal antibody that selectively targets the CD6-ALCAM pathway. This pathway plays a central role in modulating the activity and trafficking of T cells that drive a number of immuno-inflammatory diseases. Equillium acquired rights to itolizumab through an exclusive partnership with Biocon Limited.

About Equillium

Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders with high unmet medical need. Equillium is developing itolizumab for multiple severe immuno-inflammatory diseases, including aGVHD, lupus / lupus nephritis and uncontrolled asthma.

For more information, visit www.equilliumbio.com.

Forward Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the potential benefit of treating patients with aGVHD, lupus / lupus nephritis or uncontrolled asthma with itolizumab, Equillium’s business strategy, Equillium’s plans and expected timing for developing itolizumab, including the expected timing of initiating, completing and announcing further results from the EQUATE, EQUIP and EQUALISE studies, the potential benefits of itolizumab, the potential for any of Equillium’s ongoing or planned clinical trials to show safety or efficacy, and the impact of the COVID-19 pandemic. Risks that contribute to the uncertain nature of the forward-looking statements include: the risk that interim results of a clinical trial do not necessarily predict final results and that one or more of the clinical outcomes may materially change as patient enrollment continues, following more comprehensive reviews of the data, and as more patient data become available; potential delays in the commencement, enrollment and completion of clinical trials and the reporting of data therefrom; the risk that studies will not be completed as planned; uncertainties related to Equillium’s capital requirements; Equillium’s plans and product development, including the initiation, restarting and completion of clinical trials; uncertainties related to the actual impacts and length of such impacts caused by the COVID-19 pandemic; uncertainties caused by the recent restarting of the EQUIP and EQUALISE clinical trials after a pause; whether the results from clinical trials will validate and support the safety and efficacy of itolizumab; changes in the competitive landscape, and uncertainties having to use cash in ways or on timing other than expected and the impact of market volatility on cash reserves. These and other risks and uncertainties are described more fully under the caption “Risk Factors” and elsewhere in Equillium’s filings and reports with the United States Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made. Equillium undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Investor Contact

Michael Moore,
Vice President, Investor Relations & Corporate Communications
+1-619-302-4431
[email protected]

Media Contact

Katherine Carlyle Smith
Senior Account Associate
Canale Communications
+1-805-907-2497
[email protected]



Aurora Spine Announces New Pain Care Division

Company to offer products into fast growing pain management marketplace

CARLSBAD, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has created a new Pain Care Division focused on the rapidly growing segment of pain care.

Pain management has become more prevalent in recent years as neuro spine and ortho spine surgeons have changed the way they manage patients suffering from chronic back pain issues. Many practices now offer pain management and employ more pain interventionalists than spine surgeons, as there are newer products and services to help treat patients, including Aurora’s ZIP™ and SiLO™. In addition, many pain management physicians are seeking to reduce the use of opioids and increasingly using mechanical devices such as the ZIP™ and SiLO™.

The ZIP™ Screwless Fusion Procedure for the treatment of back pain is a series of patented implants developed by Aurora Spine specifically for the L5-S1 region, including Aurora Spine’s minimally invasive interspinous fixation implant designed for stabilization and load sharing in T1-S1 thoracolumbar fusion procedures.

SiLO™ is a single implant Posterior Si-Fusion System and was developed to provide a simple, safe & reproducible method of fusing the Sacroiliac Joint. SiLO™ is the only implant that was designed specifically for posterior sacroiliac joint fusions. The implant design consists of three levels of ridges along its circumferential solid body to increase implant retention and solidity through its unique “Dowel Anchorage Design”. The SiLO implant is shaped for enhanced 360-degree bone incorporation along with dual, vertical side channels.

“We are excited to announce the launch of our new Aurora Spine Pain Care division. The pain management market has experienced sizable growth in recent years and is expected to continue to grow for the foreseeable future,” said Trent Northcutt, President and CEO of Aurora Spine. “The pain care market has been a rapidly growing sector of the spinal health market. Many practices have established pain care within their practices to implement new treatments to treat back pain before sending a patient to surgery. Seeing these shifts in the market, Aurora created new products for the pain care marketplace, including products that can assist pain interventionists when treating patients and avoid or limit the use of opioids. We believe our focus on the pain care market will allow us to leverage several Aurora products into the pain care marketplace and offer patients and doctors more solutions to helping them treat chronic back pain.”

Dr. Vipul Mangal, Director of Implantable Systems at National Spine & Pain Centers in National Harbor, Maryland, stated, “Aurora Pain Care offers modern, minimally invasive treatment of back pain for my patients. Performing these cases at an outpatient surgery center is the future of minimally invasive spine surgery. I find that the device is easy to implant, and patients have had significant functional improvement in mobility and activities of daily living along with decrease in their pain.”

The global pain management devices market size is expected to reach USD $14.55 billion by 2026 registering a CAGR of 13.8%. For additional information about Aurora Spine’s Pain Care Division, go to: www.aurorapaincare.com.

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” in Aurora Spine’s final prospectus (collectively, “forward-looking information”). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine’s securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com

Adam Lowensteiner
LYTHAM PARTNERS, LLC
Phoenix | New York
Telephone: 646-829-9700
[email protected]



Sabrina Kay Appointed to MannKind Board of Directors

WESTLAKE VILLAGE, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) — MannKind Corporation (NASDAQ:MNKD) today announced that Sabrina Kay Ed.D. has been appointed to its Board of Directors, effective December 1, 2020. Dr.  Kay will also serve as a member of the Audit Committee of the Board. A serial entrepreneur, tech educator, fashion designer, philanthropist, and public speaker, Dr. Kay brings to MannKind a wealth of experience in marketing, human capital development, finance and executive leadership.

“We are excited to welcome Dr. Kay and her years of invaluable leadership to our Board of Directors,” said Kent Kresa, Chairman of the Board. “Her entrepreneurial vision will be a critical asset for MannKind as the company continues to evolve and the pipeline expands. Dr. Kay has a successful track record in launching and leading a variety of companies, and will add a fresh and diverse perspective as we continue to pursue our mission to give people control of their health and the freedom to live life.” 

Currently, Dr. Kay serves as Founder and CEO of Fremont Private Investments, where she has led the operations and exits of several companies including The Art Institute of Hollywood (sold to NASDAQ: EDMC), Premier Business Bank (sold to NASDAQ: FFWM), Fashion Umbrella, Fremont College, and Dale Carnegie of Los Angeles.

In addition to her success in the business world, Dr. Kay is a philanthropist, having served on more than 30 charitable and civic boards. She is chairman of After-School All-Stars Los Angeles, and a board member of the Los Angeles Sports and Entertainment Commission, Petersen Automotive Museum, Portal Schools, the Leadership Council of International Medical Corps Leadership Council, and the Board of Leaders of USC Marshall School. Dr. Kay has also chaired and spoken at numerous tech, education, business, and leadership conferences, and taught entrepreneurship programs at various universities.

Dr. Kay’s achievements have been recognized with numerous awards, including the Education Award from After-School All-Stars and the Humanitarian Award from International Medical Corps. She was named Woman of the Year by the California Legislature, Rising Asian Woman by the World Affairs Council, and was a finalist for Entrepreneur of the Year by Ernst & Young.

Dr. Kay received her joint doctorate degree in Work-based Learning Leadership from the University of Pennsylvania. She holds an MBA from the University of Southern California and a Master of Science degree in education from the University of Pennsylvania.

With the addition of Dr. Kay, there are nine members of the MannKind Board of Directors.

About MannKind Corporation

MannKind Corporation (NASDAQ: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company’s first FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. Words such as “believes,” “anticipates,” “plans,” “expects,” “intends,” “will,” “goal,” “potential” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon MannKind’s current expectations. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties detailed in MannKind’s filings with the SEC. For a discussion of these and other factors, please refer to MannKind’s annual report on Form 10-K for the year ended December 31, 2019 as well as MannKind’s other filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and MannKind undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.

Company Contact:

818-661-5000
[email protected]



First Quantum Files NI 43-101 for Taca Taca and Declares Maiden Mineral Reserve of Over 7.7 Million Tonnes of Contained Copper

TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“First Quantum” or “the Company”) (TSX:FM) today announced the filing of an updated National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”) Technical Report dated November, 2020 for the Taca Taca development project (the “Report”). Taca Taca is a copper, molybdenum and gold project located in the Puna (Altiplano) region of Salta Province, in northwest Argentina. The Report documents an updated Mineral Resource model and a significant maiden Mineral Reserve estimate derived from an open pit mine design and plan which contemplates processing throughput of up to 60 million tonnes per annum through a conventional flotation circuit with a mine life of approximately 32 years. The recovered copper reaches a peak of approximately 275,000 tonnes within the first ten years of operations. The design is based on the process plants which the Company has successfully constructed and operated at its Sentinel and Cobre Panama operations.

A decision to proceed with the construction of Taca Taca is not expected until sometime in 2023 or 2024. The Company remains focused on deleveraging its balance sheet over this period. Work will continue to advance the project and to further refine and optimize the plan while obtaining the required approvals and permits and suitable assurances with respect to the Argentinian fiscal regime in advance of a formal construction decision.

The updated Measured and Indicated Mineral Resource is 2,203.3 million tonnes of grading 0.43% copper for 9,450.7 kt of contained copper, 264.5 kt of molybdenum and 6,052.1 koz of gold. The Proven and Probable Mineral Reserve has been estimated at 1,758.5 Mt of ore grading 0.44% copper for 7,734.7 of contained copper, 213.5 kt of Mo and 5,086.7 koz of Au. (See Table 1 and 2. For further detail refer to the NI 43-101 Taca Taca Project, November, 2020 available on SEDAR).

This increases the Company’s total Mineral Reserves to over 29 million tonnes of contained copper which is the fifth-largest copper reserve base globally, and substantially increases the geographic diversification of the Company’s copper reserves.

Table 1: Mineral Resource statement as at October 2020, using a 0.13% Cueq cut-off grade

Classification Volume
(Mbcm)
Tonnes
(M/t)
Density
(t/m3)
Cu grade
(%)
Mo grade
(%)
Au grade
(g/t)
Cu metal
(kt)
Mo metal
(kt)
Au metal
(koz)
Measured 157.7 421.5 2.67 0.60 0.016 0.14 2,542.8 67.02 1,852.6
Indicated 671.6 1,781.8 2.65 0.39 0.011 0.07 6,908.0 197.52 4,199.5
Measured & Indicated 829.3 2,203.3 2.66 0.43 0.012 0.09 9,450.7 264.54 6,052.1
Inferred 269.4 716.9 2.66 0.31 0.009 0.05 2,206.0 65.15 1,182.7

Note: The copper equivalent cut-off (“Cueq”) grade accounts for a $3.00/lb copper price, a $1,200/oz gold price, and a $12.00/lb molybdenum price. Inventory and classification are guided by the design ultimate pit. The stated Mineral Resource includes the Mineral Reserve.

Table
2
:
Mineral
Reserve statement as at October 2020

Classification Tonnes
(M/t)
Cu grade
(%)
Mo grade
(%)
Au grade
(g/t)
Cu metal
(kt)
Mo metal
(kt)
Au metal
(koz)  
Proven 408.3 0.59 0.016 0.13 2,401.6 63.3 1,749.8
Probable 1,350.2 0.39 0.011 0.08 5,333.1 150.2 3,336.9
Proven & Probable 1,758.5 0.44 0.012 0.09 7,734.7 213.5 5,086.7

Note: The estimated Mineral Reserve was determined using metal prices of $3.00/lb for copper, $12.00/lb for molybdenum, and $1,200/oz for gold. The actual marginal cut-off grade for the Mineral Reserve varies according to the copper recovery assigned to various mineralogical groupings. However, the overall average marginal copper cut-off grade is in the order of 0.13% Cueq.

The Report also provides an update on permitting and approvals, engineering progress, detailed production planning, development designs, technical analyses, cost estimates and economic analysis. Work will continue to advance the Taca Taca project and to further refine and optimize the plan. In particular, First Quantum intends to evaluate sources of energy for the project which are more environmentally friendly, including potentially 100% renewables or a combination of renewables and natural gas, and to optimize the energy intensity of the project. The impact of the current carbon tax regime in Argentina is currently not material to the project economics; First Quantum will have full regard for the projects decarbonisation, environmental and social impact prior to the development of Taca Taca.

Qualified Persons

The Taca Taca Technical Report was prepared under the direction and supervision of the following First Quantum personnel who are Qualified Persons for the purposes of NI 43-101: David Gray (QP) BSc (Geology), MAusIMM, FAIG, Group Mine and Resource Geologist, FQM (Australia) Pty Ltd, Michael Lawlor (QP) BEng Hons (Mining), MEngSc, FAusIMM, Consultant Mining Engineer, FQM (Australia) Pty Ltd, Andrew Briggs (QP) BSc (Eng), ARSM, FSAIMM, Group Consultant Metallurgist, FQM (Australia) Pty Ltd.

The scientific and technical information regarding the Taca Taca Mineral Resource and Mineral Reserve estimates set out in this news release has been reviewed and approved by John Gregory (QP) BSc (Eng) Hons, ARSM, CEng, MIMMM, MAusIMM, Group Consultant – Mining, FQM (Australia) Pty Ltd, who is a Qualified Person as defined by NI 43-101.

For further information visit our website at www.first-quantum.com

North American contact: Lisa Doddridge, Director, Investor Relations
Tel: (416) 361-3400 Toll free: 1 (888) 688-6577
United Kingdom contact: Clive Newall, President
E-Mail: [email protected]

CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION

Certain statements and information herein, including all statements that are not historical facts, contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. The forward-looking statements include estimates, forecasts and statements as to the Company’s expectations of production, Mineral Resources and Mineral Reserves at Taca Taca, and the development of Taca Taca (including the timing, cost and details thereof) and are subject to, among other things, the impact of ore grades on future production; the potential of production disruptions; potential production, operational, labour or marketing disruptions as a result of the COVID-19 global pandemic; capital expenditure and mine production costs; a decision to pursue the development of Taca Taca; the outcome of mine permitting, other required permitting; the outcome of legal proceedings which involve the Company; information with respect to the future price of copper, gold, silver, nickel, zinc, pyrite, cobalt, iron and sulphuric acid; estimated Mineral Reserves and Mineral Resources; First Quantum’s exploration and development program; estimated future expenses; exploration and development capital requirements; and the Argentinian fiscal and regulatory regime. Often, but not always, forward-looking statements or information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate” or “believes” or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved.

With respect to forward-looking statements and information contained herein, the Company has made numerous assumptions including among other things, assumptions about continuing production at all operating facilities, the price of copper, gold, silver, nickel, zinc, pyrite, cobalt, iron and sulphuric acid, anticipated costs and expenditures and the ability to achieve the Company’s goals. Forward-looking statements and information by their nature are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. These factors include, but are not limited to, future production volumes and costs, the temporary or permanent closure of uneconomic operations, costs for inputs such as oil, power and sulphur, political stability in jurisdictions in which the Company operates, adverse weather conditions that impact the Company’s operations, labour disruptions, potential social and environmental challenges (including the impact of climate change), power supply, mechanical failures, water supply, procurement and delivery of parts and supplies to the operations, the production of off-spec material and events generally impacting global economic, political and social stability.

See the Company’s Annual Information Form dated March 30, 2020 for additional information on risks, uncertainties and other factors relating to the forward-looking statements and information. Although the Company has attempted to identify factors that would cause actual actions, events or results to differ materially from those disclosed in the forward-looking statements or information, there may be other factors that cause actual results, performances, achievements or events not to be anticipated, estimated or intended. Also, many of these factors are beyond First Quantum’s control. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company undertakes no obligation to reissue or update forward-looking statements or information as a result of new information or events after the date hereof except as may be required by law. All forward-looking statements and information made herein are qualified by this cautionary statement. 



Leviathan Announces Further Increase to Previously Announced Brokered Private Placement to $12.9 Million

VANCOUVER, British Columbia, Nov. 30, 2020 (GLOBE NEWSWIRE) — Fosterville South Exploration Ltd. (TSX-V:FSX) is pleased to announce today that, due to strong demand, Leviathan Gold Finance Ltd. (the “Company”) has agreed with Clarus Securities Inc. (“Clarus” or the “Agent”) to further increase the size of its previously announced C$9,990,000 private placement offering. Pursuant to the upsized deal terms, Clarus has agreed to sell up to 25,980,000 subscription receipts (the “Subscription Receipts”) of the Company at a price of $0.50 per Subscription Receipt to raise gross proceeds of up to $12,990,000.

The net proceeds of the Offering will be used by the Company to fund the purchase price for the Avoca and Timor projects and for general working capital.

The securities being offered have not, nor will they be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons in the absence of U.S. registration or an applicable exemption from the U.S. registration requirements. This release does not constitute an offer for sale of securities in the United States.

Closing of the Offering is expected to be on or about December 8, 2020 and is subject to regulatory approval including that of the TSX Venture Exchange.

About Fosterville South Exploration Ltd.

Fosterville South has two large, 100% owned, high-grade epizonal gold projects called the Lauriston and Golden Mountain Projects, a large group of tenement applications called the Providence Project and a large group of recently consolidated tenement applications called the Walhalla Belt Project, all in the state of Victoria, Australia. The Fosterville South land packaged, assembled over a multi-year period, notably includes a 600 sq. km property immediately to the south of and within the same geological framework that hosts Kirkland Lake Gold’s Fosterville tenements. Additionally, Fosterville South has gold-focused projects called the Moormbool, Timor and Avoca Projects, which are also located in the state of Victoria, Australia.

Six of Fosterville South’s properties (Lauriston, Providence, Golden Mountain, Timor, Avoca and Walhalla Belt) have had historical gold production from hard rock sources despite limited modern exploration and drilling.

On behalf of Fosterville South
Bryan Slusarchuk
Chief Executive Officer and Director

Adam Ross, Investor Relations
Direct : (604) 229-9445
Toll Free: 1(833) 923-3334
Email: [email protected]

Forward-Looking Statements

Information set forth in this news release contains
forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs,
intentions
and expectations. They are not
guarantees
of future performance. Fosterville South ca
utions that all
forward looking
statements are inherently uncertain and that actual performance may be affected by many material factors, many of which are beyond their respective control. Such factors include, among other things: risks and uncertainties r
elating to Fosterville South’s
and the Company’s limited operating histories, the
completion of the financing and the need to comply with regulations.  Accordingly,
actual
and future events, conditions and results may differ materially from the estimates,
beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Fosterville South does not undertake to publicly update or revise forward-looking information.


Neither


TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.



Merriam-Webster Announces “Pandemic” as 2020 Word of the Year

Springfield, MA, Nov. 30, 2020 (GLOBE NEWSWIRE) — Merriam-Webster, the dictionary publisher helping millions of people understand and use language better, has announced its Word of the Year for 2020: pandemic. While the COVID-19 pandemic that has defined 2020 in many ways might make the word seem like a natural choice, the selection is entirely data driven: pandemic was looked up at Merriam-Webster.com in 2020 with remarkable frequency throughout the entire year and in numbers that far exceeded 2019 lookups. In this exceptional year the data was exceptionally clear: the story of the year is the word of the year. Other words also stood out in the dictionary’s 2020 data, and they too shed light on the experiences and ideas that shaped the year.

Lookups of pandemic first spiked on February 3rd, when the first COVID-19 patient in the U.S. was released from the hospital, but close inspection of the dictionary data shows that searches for the word began to tick up consistently starting on January 20th, the date of the first positive case in the U.S. That initial February spike in lookups didn’t fall off—it grew, with dictionary users looking up pandemic an average of 4,000% more in early March than they had been a year previous. The World Health Organization’s March 11th declaration “that COVID-19 can be characterized as a pandemic” pushed lookups into the ether: that day pandemic saw the single largest spike in dictionary traffic in 2020, increasing 115,806% over its 2019 lookups. The word remained high for the remainder of the year.

 “Pandemic is the word that has connected the worldwide medical emergency with the political response and with our personal experience of it all,” says Peter Sokolowski, Editor at Large for Merriam-Webster. “Words that might be part of our general vocabulary send us to the dictionary when they suddenly seem technical, medical, or legal. The word pandemic, though familiar, came into the news this year with an urgent specificity.” 

Gallery: Get more detail on all the 2020 Words of the Year

Other top lookups include malarkey, an old-fashioned word that’s a favorite of President-elect Joe Biden, and one he used several times during the presidential debate in October. The word is defined as “insincere or foolish talk.”

Entertainment and sports also inspired people to turn to the dictionary. The word kraken saw a large spike in lookups when Seattle’s brand-new National Hockey League franchise chose the word as its team name. Nomenclature was also behind searches for antebellum. In June, an award-winning musical trio announced a name change: “Lady Antebellum” would now officially be called “Lady A”; and in September a horror movie using the word as its title was released.

The dictionary’s data also opened a window onto the thoughts of people processing the loss of some prominent and beloved Americans. Mamba rose high in the lookups when basketball great Kobe Bryant, whose nickname was Black Mamba, died in January, and searches for the word icon climbed in reaction to the deaths of both Representative John Lewis in July and Supreme Court Justice Ruth Bader Ginsburg in September.

Podcast: Listen to Merriam-Webster editors discuss the Word of the Year

“The words that rise to prominence when we examine our data at the year’s end always say something about our collective experience. In this case, the Word of the Year is one that has truly touched us all. Pandemic is not only an important medical term; it’s likely that this period of time will be forever known by this word,” says Sokolowski.

Attachment



Meghan Lunghi
Merriam-Webster Inc.
4137343134 x8152
[email protected]

Interim Results for the Period Ended September 30, 2020

Highlights and subsequent events

  • Golar LNG Partners LP (“Golar Partners” or “the Partnership”) generated operating income of $32.1 million for the third quarter of 2020, exclusive of its interest in FLNG Hilli Episeyo.
  • After accounting for $1.1 million of non-cash mark-to-market interest rate swap losses, the Partnership reported net income attributable to unit holders of $17.4 million for the third quarter.
  • The Partnership generated distributable cash flow1 of $20.7 million for the third quarter resulting in a distribution coverage ratio1 of 14.50.
  • The Partnership entered into a cooperation agreement with Hygo Energy Transition Limited (“Hygo”), formerly known as Golar Power Limited, to develop terminals using Golar Partners’ asset portfolio.
  • Increased utilization of the carrier Golar Maria helped lift the Partnership’s overall fleet utilization to 98% for the quarter.
  • The Partnership declared a distribution for the third quarter of $0.0202 per unit.

Financial Results Overview

Golar Partners reports net income attributable to unit holders of $17.4 million and operating income (which excludes its share of Hilli Episeyo which is accounted for under the equity method) of $32.1 million for the third quarter of 2020 (“the third quarter” or “Q3”), as compared to net income attributable to unit holders of $14.3 million and operating income of $32.8 million for the second quarter of 2020 (“the second quarter” or “Q2”) and net income attributable to unit holders of $7.9 million and operating income of $35.9 million for Q3 2019.

Consolidated GAAP Financial Information
(in thousands of $) Q3 2020 Q2 2020 Q3 2019
Total Operating Revenue 71,113    72,114    75,818   
Vessel Operating Expenses (14,015)   (12,991)   (14,740)  
Voyage and Commission Expenses (1,571)   (2,359)   (1,685)  
Administrative Expenses (3,427)   (3,913)   (3,110)  
Operating Income 32,117    32,805    35,903   
Interest Income 4,203    4,615    4,990   
Interest Expense (17,805)   (17,115)   (19,764)  
Losses on Derivative Instruments, net (1,051)   (4,472)   (9,937)  
Net income attributable to Golar LNG Partners LP Owners 17,360    14,264    7,924   

Non-GAAP Financial Information1
(in thousands of $) Q3 2020 Q2 2020 Q3 2019
Adjusted Interest Income 114    416    925   
Adjusted Net Debt 1,438,258    1,483,319    1,551,154   

Segment Information2
  Q3 2020 Q2 2020 Q3 2019
(in thousands of $) FSRU* LNG Carrier* FLNG** Total FSRU* LNG Carrier* FLNG** Total FSRU* LNG Carrier* FLNG** Total
Total Operating Revenues 58,276    12,837    26,018    97,131    59,033    13,081    26,018    98,132    63,490    12,328    26,018    101,836   
Amount invoiced under sales-type lease 4,600    —    —    4,600    4,550    —    —    4,550    4,600    —    —    4,600   
Adjusted Operating Revenues 1 62,876    12,837    26,018    101,731    63,583    13,081    26,018    102,682    68,090    12,328    26,018    106,436   
Voyage and Commission Expenses (1,450)   (121)   —    (1,571)   (935)   (1,424)   —    (2,359)   (1,002)   (683)   —    (1,685)  
Vessel Operating Expenses (9,627)   (4,388)   (6,048)   (20,063)   (8,525)   (4,466)   (5,611)   (18,602)   (9,542)   (5,198)   (5,686)   (20,426)  
Administrative Expenses (2,093)   (1,334)   (121)   (3,548)   (2,469)   (1,444)   (122)   (4,035)   (1,870)   (1,240)   (223)   (3,333)  
Total Adjusted EBITDA1 49,706    6,994    19,849    76,549    51,654    5,747    20,285    77,686    55,676    5,207    20,109    80,992   

* Indirect administrative expenses are allocated to the FSRU and LNG carrier segments based on the number of vessels.
** Relates to effective share of revenues and expenses attributable to our investment in Golar Hilli LLC (“Hilli LLC”) had we consolidated our 50% ownership of the Hilli common units.

In order to incorporate the economic performance of the FSRU Golar Freeze into total company performance, management has determined that it will measure the performance of the Golar Freeze sales-type lease based on Adjusted EBITDA1 (EBITDA as adjusted for the amount invoiced under sales-type lease in the period).

The Partnership’s Q3 Adjusted Operating Revenues1 including amounts invoiced under the Golar Freeze sales-type lease and the Partnership’s effective share of operating revenues from FLNG Hilli Episeyo, decreased by $1.0 million relative to Q2. The decrease from $102.7 million to $101.7 million was primarily the result of a scheduled step down in the daily rate earned for one of the Partnership’s FSRUs after passing a five-year service milestone. Voyage and commission expenses at $1.6 million decreased by $0.8 million relative to the second quarter. Reduced bunker consumption by the Golar Maria which experienced less idle time during the quarter accounts for much of this decrease. Having spent a full quarter in layup, Golar Mazo was not included in utilization or fleet wide average daily time charter earnings1 (“TCE”) calculations in Q3. As a result, both utilization and TCE1 improved. Utilization increased from 92% in Q2 to 98% in Q3 whilst TCE1 increased from $96,300 in Q2 to $100,700 in Q3.

Vessel operating expenses increased by $1.5 million from $18.6 million in Q2 to $20.1 million in Q3. Additional crew costs continue to be incurred as a result of the complex logistics associated with crew changes during the COVID outbreak. In anticipation of the FLNG Hilli Episeyo’s annual maintenance window in early October, additional spares were also purchased during the quarter. Lower legal and professional fees account for much of the $0.5 million decrease in administrative expenses, which reduced from $4.0 million in Q2 to $3.5 million in Q3.

Interest expense increased $0.7 million from $17.1 million in Q2 to $17.8 million in Q3. A full quarter’s interest expense on the two May 20, 2020 amended high yield bonds at a higher margin and recognition of a potential 5% premium payable at maturity on each bond was partially offset by the impact of a decrease in LIBOR and ongoing debt principal repayments.

Losses on derivative instruments reduced by $3.4 million from $4.5 million in Q2 to $1.1 million in Q3 due to a small increase in longer-term swap rates during the quarter that resulted in a mark-to-market gain on interest rate swaps. As of September 30, 2020, the average fixed interest rate of swaps related to bank debt, including the Partnership’s effective share in respect of Hilli Episeyo was approximately 2.3%.

Declaration of the third quarter dividend in respect of FLNG Hilli Episeyo was delayed until costs associated with its scheduled  early October maintenance window had been accurately estimated. The Partnership received its third quarter dividend in October. Q3 distributable cash flow1 and the distribution coverage ratio1 decreased accordingly, to $20.7 million and 14.5 respectively.

Operational Review

Utilization increased during the quarter, from 92% in Q2 to 98% in Q3, driven by a full quarter in layup for the Golar Mazo and fewer idle days for the Golar Maria.

FLNG Hilli Episeyo, which completed its scheduled maintenance window in October, on time and without issue, continues to maintain 100% commercial uptime. It recently offloaded its 47th cargo and continues to reliably deliver quarterly LNG tolling revenues, less operating costs, of around $40 million; 50% of which is for GMLP’s account.

Although some of the tasks postponed as a result of COVID related movement restrictions have been carried out, it has not been possible to do everything planned. Operating costs did not therefore increase to the extent expected in Q3 and ongoing restrictions mean that some tasks will be further deferred, possibly to the spring of 2021. Despite the additional challenges posted by the current operating environment, the Partnership was pleased to note that the FSRU Golar Winter recently completed four consecutive years with zero lost time incidents (“LTI”), equivalent to 1.2 million LTI free exposure hours. Following the recent launch of an energy management initiative, fuel performance for the carrier fleet under Golar’s management has also improved significantly, saving our customers money, and, more importantly, helping the environment in the process.

Financing and Liquidity

As of September 30, 2020, Golar Partners had cash and cash equivalents of $42.3 million. Including the Partnership’s $397.5 million share of debt in respect of FLNG Hilli Episeyo, Adjusted Net Debt1 as at September 30, 2020 was $1,438.3 million. Q3 2020 Total Adjusted EBITDA1 amounts to $76.5 million. Based on the above, the Q3 Adjusted Net Debt1 to Annualized Adjusted EBITDA1 ratio was 4.7x. As of September 30, 2020, exclusive of a $100.0 million forward start swap, Golar Partners had interest rate swaps with a notional outstanding value of approximately $1,152.3 million (including swaps with a notional value of $250.0 million in connection with the Partnership’s bonds and $397.5 million in respect of Hilli Episeyo), representing approximately 78% of total debt and finance lease obligations, including assumed debt in respect of Hilli Episeyo, net of restricted cash.

The average fixed interest rate of swaps related to bank debt, including the Partnership’s effective share in respect of Hilli Episeyo is approximately 2.3% with an average remaining period to maturity of approximately 3.1 years as of September 30, 2020.

Inclusive of Hilli Episeyo related debt, outstanding bank debt as of September 30, 2020, was $1,157.0 million, which had average margins, in addition to LIBOR, of approximately 2.19%. As at September 30, 2020, the Partnership also had a November 2021 maturing $150.0 million amortizing Norwegian USD bond with a coupon of LIBOR plus 6.25% and a November 2022 maturing $250 million amortizing Norwegian USD bond with a coupon of LIBOR plus 8.1%. Both bonds have call options at 100% of par until May 2021 and at 105% until maturity thereafter. Inclusive of the accumulated accretion of the potential 5% premium payable at maturity and net of amounts repaid, $146.5 million was outstanding in respect of the November 2021 maturing bond and $246.6 million was outstanding in respect of the November 2022 maturing bond, as at September 30, 2020. Given the low interest rate environment and plans to refinance both bonds ahead of their new maturity dates, the Partnership has refrained from entering into new contracts to replace those bond related swaps that matured during Q2 or to extend the duration of those that remain.

The Partnership has now obtained credit approval from lead banks in connection with the refinancing of the 7-vessel $800 million facility, of which, as at September 30, 2020, $529 million was outstanding. Expectations are this could be increased after a syndication exercise.

Corporate and Other Matters

As of September 30, 2020, there were 70,738,027 common and general partner units outstanding in the Partnership. Of these, 22,769,977, including 1,436,391 general partner units, were owned by Golar, representing a 32.2% interest in the Partnership.   

On October 27, 2020, Golar Partners declared a distribution for the second quarter of $0.0202 per unit. This distribution was paid on November 13, 2020 to common and general partner unit holders of record as at November 6, 2020.

A cash distribution of $0.546875 per Series A preferred unit for the period covering August 15, 2020 through to November 14, 2020 was also declared. This was paid on November 16, 2020 to all Series A preferred unit holders of record as at November 9, 2020.

Total outstanding and exercisable options as at September 30, 2020 were 24,000. A further 58,960 Restricted Stock Units are in issue which will vest over three years.

At the Partnership’s Annual General Meeting on September 24, Neil Glass was elected as a Class I Director and Carl Steen was elected as a Class II Director. Neil Glass has also been appointed to the Partnership’s Audit Committee.

LNG Market Review

The quarter commenced with JKM at around $2.15/mmbtu and quoted steam turbine (“ST”) headline spot rates of around $20k/day. Further US cargo cancellations over the summer months and higher than normal European storage levels resulted in a slower seasonal recovery in shipping rates. Hurricane related interruptions also cut US supply in early September and contributed to a buildup of tonnage in the Atlantic. This temporarily halted carrier rate increases being seen from late August and further boosted LNG prices that were increasing as a result of earlier supply re-balancing. As production resumed, a widening of the west-east arbitrage quickly absorbed available vessels and freight rates resumed their upward seasonal trajectory. The quarter ended with JKM at around $5.15/mmbtu and quoted ST headline spot rates of around $43k/day.

Full utilization of available US export capacity and increasingly long haul trades are currently supported by strong winter demand in key Asian markets and supply outages elsewhere, leading to higher LNG prices and widening regional price differentials into Q4. The LNG Carrier, Golar Maria is expected to achieve around 80% utilization for Q4 and record a TCE1 similar to that achieved in Q3. Her term contract is scheduled to commence around the end of this year.

Up to 20-25 million tons of unutilized liquefaction capacity may return to the market in 2021. Growing underlying demand and limited new nameplate capacity additions through to 2023 are expected to result in LNG prices that do not compromise its competitiveness relative to other less environmentally friendly fuels but do support a more sustained increase in US-Asia trade and ton-mile demand for shipping.

Golar Partners agreed with Hygo on August 31 to terminate the existing omnibus agreement between the two parties and to replace that with a new cooperation agreement. The intention of the cooperation agreement is that both parties will work together to develop hub-spoke LNG terminal solutions utilizing Golar Partners’ available asset portfolio, where those assets are suitable. The terms and structure of the commercial cooperation will be worked on a project by project basis given the customized nature of each potential terminal. As well as leveraging the expertise of the Hygo team to develop FSRU terminals and parcel regasification demand, this agreement will, alongside normal FSRU tendering activity, increase the Partnership’s re-contracting options, and provide an opportunity to potentially earn higher returns than those typically available from standard FSRU contracts in the current market.

Outlook

Golar Partners will, together with the Hygo team, commence work on assessments of the addressable markets for small scale LNG distribution and fuel switching opportunities for larger industrial users in the regions around the Partnership’s FSRUs.

As expected, LNG carrier spot rates have improved substantially in recent months in line with seasonality. This will have little impact on the Partnership’s expected total adjusted EBITDA1 for Q4 which is expected to be broadly similar to Q3, however it does reflect a firming underlying demand for LNG and a gradual return to more traditional trading patterns. This can create upward pressure on ton miles over the coming years resulting in a more supportive backdrop for re-contracting or extending the current Golar Grand charter in May 2021.

FORWARD LOOKING STATEMENTS

This press release contains certain forward-looking statements concerning future events and Golar Partners’ operations, performance and financial condition. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain the words “believe,” “anticipate,” “expect,” “estimate,” “project,” “will be,” “will continue,” “will likely result,” “plan,” “intend” or words or phrases of similar meanings. These statements involve known and unknown risks and are based upon a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond Golar Partners’ control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially include, but are not limited to:

  • the ability of Golar LNG Partners LP (“Golar Partners,” “we,” “us” and “our”) and Golar LNG Limited’ (“Golar”) to make additional borrowings and to access debt and equity markets;
  • our ability to repay our debt when due and to settle our interest rate swaps;
  • our ability to enter into long-term time charters, including our ability to re-charter floating storage and regasification units (“FSRUs”), liquefied natural gas (“LNG”) carriers and floating liquefied natural gas units (“FLNGs”) following the termination or expiration of their time charters;
  • our ability to maximize the use of our vessels, including the re-deployment or disposal of vessels no longer under long-term time charter;
  • the length and severity of outbreaks of pandemics, including the recent worldwide outbreak of the novel coronavirus (“COVID-19”) and its impact on demand for LNG and natural gas, the operations of our charterers, our global operations and our business in general;
  • the liquidity and creditworthiness of our charterers;
  • the effect of a worldwide economic slowdown;
  • changes in commodity prices;
  • turmoil in the global financial markets;
  • fluctuations in currencies and interest rates;
  • market trends in the FSRU, LNG carrier and FLNG industries, including fluctuations in charter hire rates, vessel values, factors affecting supply and demand, and opportunities for the profitable operations of FSRUs, LNG carriers and FLNGs;
  • availability of skilled labor, vessel crews and management, including possible disruptions caused by the COVID-19 outbreak;
  • our vessel values and any future impairment charges we may incur;
  • disruption of shipping routes due to accidents, political events, piracy or acts by terrorists;
  • future sales of our securities in the public market;
  • our anticipated growth strategies;
  • the future share of earnings relating to the FLNG, Hilli Episeyo (“Hilli”), which is accounted for under the equity method;
  • our ability to integrate and realize the expected benefits from acquisitions and potential acquisitions;
  • our ability to make cash distributions on our units and the amount of any such distributions;
  • changes in our operating expenses, including dry-docking and insurance costs and bunker prices;
  • estimated future maintenance and replacement capital expenditures;
  • our future financial condition or results of operations and future revenues and expenses;
  • planned capital expenditures and availability of capital resources to fund capital expenditures;
  • the exercise of purchase options by our charterers;
  • our ability to maintain long-term relationships with major LNG traders;
  • our ability to leverage the relationships and reputation of Golar and Hygo Energy Transition Ltd. (“Hygo”), formerly known as Golar Power Limited, in the LNG industry;
  • the ability of Golar and us to retrofit vessels as FSRUs or FLNGs and the timing of the delivery and acceptance of any such retrofitted vessels by their respective charterers;
  • our ability to purchase vessels from Golar and Hygo in the future;
  • timely purchases and deliveries of new build vessels;
  • future purchase prices of new build and secondhand vessels;
  • our ability to compete successfully for future chartering and newbuilding opportunities;
  • acceptance of a vessel by its charterer;
  • termination dates and extensions of charters;
  • the expected cost of, and our ability to comply with, governmental regulations, maritime self-regulatory organization standards, as well as standard regulations imposed by our charterers applicable to our business;
  • our general and administrative expenses and our fees and expenses payable under the fleet management agreements and the management and administrative services agreement between us and Golar Management (or the “Management and Administrative Services Agreement”);
  • challenges by authorities to the tax benefits we previously obtained;
  • the anticipated taxation of our partnership and distributions to our unitholders;
  • economic substance laws and regulations adopted or considered by various jurisdictions of formation or incorporation of us and certain of our subsidiaries;
  • our and Golar’s ability to retain key employees;
  • customers’ increasing emphasis on environmental and safety concerns;
  • potential liability from any pending or future litigation; and
  • other factors listed from time to time in the reports and other documents that we file with the U.S. Securities and Exchange Commission (the “SEC”).

Factors may cause actual results to be materially different from those contained in any forward-looking statement. Golar Partners does not intend to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Golar Partners’ expectations with respect thereto or any change in events, conditions or circumstances on which any such statement is based.

November 30, 2020
Golar LNG Partners L.P.
Hamilton, Bermuda
Questions should be directed to:
c/o Golar Management Ltd – +44 207 063 7900
Karl Fredrik Staubo – Chief Executive Officer
Stuart Buchanan – Head of Investor Relations

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachment



Seaport Global Acquisition Corp. Announces Pricing of $125,000,000 Initial Public Offering

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) — Seaport Global Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 12,500,000 units, at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and will begin trading today, Monday, November 30, 2020, under the ticker symbol “SGAMU.” Each unit consists of one share of the Company’s Class A common stock and three-quarters of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “SGAM” and “SGAMW,” respectively.

The offering is expected to close on December 2, 2020, subject to customary closing conditions.

The Company is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus its search on companies emerging from a reorganization or distressed situation. The Company is led by Chairman and Chief Executive Officer, Stephen C. Smith, and Chief Financial Officer, Michael Ring. In addition to Messrs. Smith and Ring, the Board of Directors includes Jay Burnham, Shelley Greenhaus, Jeremy Hedberg and Charles Yamarone.
        

B. Riley Securities, Inc. is acting as sole book-running manager of the offering. The Company has granted B. Riley Securities, Inc. a 45-day option to purchase up to an additional 1,875,000 units at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus. Copies of the preliminary prospectus relating to the offering and final prospectus, when available, may be obtained from B. Riley Securities, Inc. at 1300 17th Street N., Suite 1400, Attn: Syndicate Prospectus Department, Arlington, Virginia 22209, by telephone at (800) 846-5050 or by email at [email protected].

A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission (“SEC”) on November 27, 2020.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact

Stephen C. Smith
Chairman and Chief Executive Officer
Seaport Global Acquisition Corp.
360 Madison Avenue, 20th Floor
New York, NY 10017
Telephone: 212-616-7700 



Corning to Provide Financial Update at Credit Suisse Annual Technology Conference

Company expects strong sales and earnings growth in the fourth quarter

CORNING, NY, Nov. 30, 2020 (GLOBE NEWSWIRE) — At today’s Credit Suisse Annual Technology Conference, Corning Incorporated (NYSE: GLW) Chief Strategy Officer Dr. Jeffrey Evenson will provide investors with an update about the company’s expected financial performance in the fourth quarter of 2020.

Highlights of Dr. Evenson’s remarks will include:

  • Fourth-quarter sales are expected to grow 5% to 8% sequentially  
     
  • Operating margin is expected to grow at approximately double the rate of sales sequentially

Dr. Evenson will tell conference attendees, “Despite a challenging macro environment, we continue to perform well and deliver meaningful accomplishments across the company. The relevance of our capabilities and our relationships with industry leaders are creating new opportunities for us to support customers with more Corning content. We are generating top- and bottom-line growth in multiple businesses and our strategic investments are paying off. Overall, our performance demonstrates the strength of Corning’s portfolio and our ability to execute.”

Corning’s presentation to investors will be available via webcast by accessing the investor events calendar on Corning’s Investor Relations website at www.corning.com/investor_relations.

Forward-Looking and Cautionary Statements

This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the duration and severity of the recent COVID-19 (coronavirus) outbreak, and its ultimate impact across our businesses on demand, operations and our global supply chains; the effects of acquisitions, dispositions and other similar transactions by the Company, the effect of global business, financial, economic and political conditions; tariffs and import duties; currency fluctuations between the U.S. dollar and other currencies, primarily the Japanese yen, New Taiwan dollar, euro, Chinese yuan, and South Korean won; product demand and industry capacity; competitive products and pricing; availability and costs of critical components and materials; new product development and commercialization; order activity and demand from major customers; the amount and timing of our cash flows and earnings and other conditions, which may affect our ability to pay our quarterly dividend at the planned level or to repurchase shares at planned levels; possible disruption in commercial activities due to terrorist activity, cyber-attack, armed conflict, political or financial instability, natural disasters, or major health concerns; unanticipated disruption to equipment, facilities, IT systems or operations; effect of regulatory and legal developments; ability to pace capital spending to anticipated levels of customer demand; rate of technology change; ability to enforce patents and protect intellectual property and trade secrets; adverse litigation; product and components performance issues; retention of key personnel; customer ability, most notably in the Display Technologies segment, to maintain profitable operations and obtain financing to fund their ongoing operations and manufacturing expansions and pay their receivables when due; loss of significant customers; changes in tax laws and regulations including the Tax Cuts and Jobs Act of 2017; and the potential impact of legislation, government regulations, and other government action and investigations.

For a complete listing of risks and other factors, please reference the risk factors and forward-looking statements described in our annual reports on Form 10-K and quarterly reports on Form 10-Q. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

Web Disclosure

In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated (“Corning”) wishes to notify investors, media, and other interested parties that it uses its website (http://www.corning.com/worldwide/en/about-us/news-events.html) to publish important information about the company, including information that may be deemed material to investors, or supplemental to information contained in this or other press releases. The list of websites and social media channels that the company uses may be updated on Corning’s media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company’s SEC filings, press releases, conference calls, and webcasts.

About Corning Incorporated

Corning (www.corning.com) is one of the world’s leading innovators in materials science, with a 169-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramic science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people’s lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries. Corning’s capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping our customers capture new opportunities in dynamic industries. Today, Corning’s markets include optical communications, mobile consumer electronics, display, automotive, and life sciences.

Media Relations Contact:    
Gabrielle Bailey                                                         
(607) 974-6394                                                          
[email protected]                                               
           
Investor Relations Contact:
Ann H.S. Nicholson
(607) 974-6716
[email protected]